Lansoprazole tablets
Function and Efficacy
This product is a benzimidazole compound. After oral absorption, it is transferred to the gastric mucosa and converted into an active metabolite under acidic conditions. The activated body specifically inhibits the H/K-ATPase system of gastric parietal cells and blocks the final step of gastric acid secretion. This product inhibits basal gastric acid secretion and gastric acid secretion under stimulation in a dose-dependent manner. This product has no antagonistic effect on choline and amine H2 receptors.
Ingredients
Lansoprazole
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LansoprazoleIngredients |
This product is a benzimidazole compound. After oral absorption, it is transferred to the gastric mucosa and converted into an active metabolite under acidic conditions. The activated body specifically inhibits the H/K-ATPase system of gastric parietal cells and blocks the final step of gastric acid secretion. This product inhibits basal gastric acid secretion and gastric acid secretion under stimulation in a dose-dependent manner. This product has no antagonistic effect on choline and amine H2 receptors. More |
103577-45-3 | 87 |
Appearance
This product is a white enteric-coated tablet, which appears white or off-white after removing the enteric coating.
Indication
Gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome.
Usage and Dosage
Adults usually take lansoprazole tablets orally, once a day, two tablets (30 mg) at a time. For duodenal ulcer, take it continuously for 4-6 weeks; for gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome, take it continuously for 6-8 weeks; or as directed by a doctor.
Adverse Reactions
(1) Allergies: Occasionally, there may be symptoms such as rash and itching. If the above symptoms occur, please stop taking the drug. (2) Blood system: Occasionally, there may be symptoms such as anemia, leukopenia, eosinophilia, etc., and symptoms of thrombocytopenia rarely occur. (3) Digestive system: Occasionally, there may be symptoms such as constipation, diarrhea, thirst, and abdominal distension. Occasionally, there may be an increase in ALT, AST, ALP, LDH, and γ-GTP, so careful observation is required. If there are any abnormalities, appropriate measures such as discontinuation of the drug should be taken. (4) Mental and nervous system: Occasionally, there may be symptoms such as headache and drowsiness. Insomnia and dizziness rarely occur. (5) Others: Occasionally, there may be symptoms such as fever, increased total cholesterol, and increased uric acid.
Precautions
Those who are allergic to this product are prohibited
Special Population Medication
Precautions for children: The safety of the drug for children has not been established (there is very little clinical experience in children). Precautions for pregnancy and lactation: Pregnant and lactating women should not use. Precautions for the elderly: Generally speaking, the gastric acid secretion capacity and other physiological functions of elderly patients will be reduced, so please pay attention during medication.
Drug Interactions
Lansoprazole will delay the metabolism and excretion of diazepam and phenytoin, increase the peak blood concentration of acetaminophen, and shorten the time to reach the peak.
Storage
Keep away from light and store in sealed container.
Packaging Specification
15mg
Validity Period
24 months.
Manufacturer
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
-
Founded in:
2001-11-30 -
Address:
Luoqi Road, Linyi High-tech Industrial Development Zone, Shandong Province -
Tax NO.:
913700002658705037 -
Registered Funds:
60.96 million yuan -
Website:
-
Email: